Ashkan Shahbandi

Years Active: 2019-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Ashkan Shahbandi, Fang-Yen Chiu, Nathan A Ungerleider, Raegan Kvadas, Zeinab Mheidly, Meijuan J S Sun, Di Tian, Daniel A Waizman, Ashlyn Y Anderson, Heather L Machado, Zachary F Pursell, Sonia G Rao, James G Jackson
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80. Nature cancer (2022)
Crystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, Ashkan Shahbandi, Nathan A Ungerleider, Joie O Olayiwola, Lucas B Murray, Benjamin T Vinson, Douglas B Chrisey, Christopher J Lord, James G Jackson
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival. The Journal of cell biology 218 (11) (2019)

Ashkan Shahbandi.css-eqlu8i{font-size:small;padding-left:4px;}